Helius Medical Technologies (HSDT)
(Delayed Data from NSDQ)
$0.83 USD
+0.02 (2.71%)
Updated Sep 19, 2024 03:57 PM ET
After-Market: $0.83 0.00 (0.55%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HSDT 0.83 +0.02(2.71%)
Will HSDT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for HSDT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HSDT
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
HSDT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Predict a 1249.93% Upside in Helius Medical Technologies, Inc. (HSDT): Here's What You Should Know
How Much Upside is Left in Helius Medical Technologies, Inc. (HSDT)? Wall Street Analysts Think 1183.3%
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates
Other News for HSDT
Helius Medical Technologies Inc (HSDT) Stock Price Up 8.97% on Sep 9
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Helius Medical Technologies Inc (HSDT) Q2 2024 Earnings Call Transcript Highlights: Revenue ...
Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results
Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript